Investment Considerations The company combines proprietary imaging hardware, FDA-cleared AI applications, cloud software, radiology services and healthcare IT within an end-to-end platform spanning scan, analysis and interpretation. Nanox is expanding its commercial reach through its U.S. commercial activities, partnership agreements, and collaboration with healthcare organizations. Second-quarter 2026 revenue increased to $4.2 million from $3.0 million … Continue reading “Nano-X Imaging Ltd. (NASDAQ: NNOX)”
| Symbol | Release | Time |
|---|---|---|
| {{ release.qmtopics.qmsymbol[0].symbol }} | {{ release.headline }} | {{ release.datetime | amDateFormat:'hh:mm A'}} |